Similar Articles
Hematin in Acute Porphyria Neuropathy
Vedat Ali YÜREKLİ, Galip AKHAN, Mehmet Numan TAMER
Experiences of lnterferon Beta-1b Treatment After 5-Year Follow-U
Serkan ÖZAKBAŞ, Egemen İDİMAN, Burak PAKÖZ, Berril DÖNMEZ, Utku UYSAL
Mitochondrial Disorders and Treatment
Alev LEVENTOĞLU, Reha KURUOĞLU
Antiphospholipid Antibody Syndrome: Case Report
Hacer US ANAÇ, Işıl KALYONCU, Hülya KARASULU, Dursun KIRBAŞ
Obstetrical Brachial Plexus Palsy: Outcome with Conservative Managementand Factors Effecting the Prognosis
Okter AMAÇ, Ferah GENEL, Füsun ATLIHAN, İbrahim ÖZTURA, Nedret URAN
Facial F Waves And Ephaptic Abnormal Muscle Responsesin Hemifacial Spasm:Evaluation Of Pathophysiology And Effect Of Botulinum Toxim Therapy
Cengiz TATAROĞLU, Raif ÇAKMUR, Fethi İDİMAN
Paroxysmal Dyskinesia: Report of Four Cases
Funda UYSAL TAN, Hatice BALABAN, Sedat ULKATAN, Cenk AKBOSTANCI
lron Deficiency and Restless Legs Syndrome; Three Cases
C. TOGAY IŞIKAY, A. BİNGÖL, N. MUTLUER
Subacute Myleo-Optic Neuropathy- Case Report
Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.
Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil
DOI: 10.55697/tnd.2025.216
Efficacy and safety of intravenous thrombolytic therapy in acute ischemic stroke: Predictors of good prognosis and outcomes of the elderly population
Burak Gürel, Vedat Ali Yürekli
DOI: 10.55697/tnd.2026.578
Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis
Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci
DOI: 10.55697/tnd.2026.622